DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX
0550.716.015 · rovalta.com · 28/09/2026
ACTIVE
DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX
Financial year 2025 · Closed on 30/06/2025
Net result132,2 k €+33,8 %over 1 year
Gross margin274,1 k €+22,5 %over 1 year
Equity1 M €+14,5 %over 1 year
Overview
Identity
Source · BCE/KBODR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX is a Private limited company incorporated in 2014. Its main activity is: Specialist medical practice activities. Its registered office is in Braine-l'Alleud.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0550.716.015
- Incorporation
- 10/04/2014
- Legal form
- Private limited company
- Registered office
- Clos Béliau 16
1421 Braine-l'Alleud · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Activities (NACE)
Joint committees (2)
- 200
- 330
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 12 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 274,1 k € | +22.5% | 223,8 k € | -34.6% | 342,1 k € | +2.7% | 333,1 k € | +51.0% | 220,6 k € |
| EBITDA | 235,5 k € | +23.3% | 191 k € | -37.7% | 306,5 k € | +2.1% | 300,1 k € | +59.1% | 188,6 k € |
| Operating result | 204,5 k € | +24.7% | 164 k € | -39.9% | 272,6 k € | +9.9% | 248 k € | +74.5% | 142,1 k € |
| Net result | 132,2 k € | +33.8% | 98,8 k € | -46.4% | 184,3 k € | +9.1% | 168,9 k € | +83.3% | 92,1 k € |
| Balance sheet | |||||||||
| Equity | 1 M € | +14.5% | 909 k € | +12.2% | 810,2 k € | +29.4% | 625,9 k € | +12.2% | 557,9 k € |
| Total assets | 1,5 M € | -4.9% | 1,6 M € | +9.0% | 1,4 M € | +12.0% | 1,3 M € | +23.8% | 1 M € |
| Cash | 250,3 k € | +3.6% | 241,7 k € | -64.2% | 674,9 k € | -22.9% | 875,6 k € | -7.7% | 949,2 k € |
| Debts | 415,2 k € | -33.4% | 623,8 k € | +3.5% | 602,6 k € | -5.4% | 637,1 k € | +36.3% | 467,4 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| DirectorManagerended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Marc LEBLANC | DirectorManager |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 04/12/2025 | 06/02/2025 | 31/01/2024 | 19/12/2022 | 13/12/2021 | 17/12/2020 |
| General meeting | 04/12/2025 | 30/01/2025 | 29/01/2024 | 30/11/2022 | 10/12/2021 | 11/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 04/12/2025 | 04/12/2025 | French | |
| Micro modelCorrection | 30/06/2024 | 30/01/2025 | 06/02/2025 | French | |
| Micro model | 30/06/2024 | 30/01/2025 | 31/01/2025 | French | |
| Micro model | 30/06/2023 | 29/01/2024 | 31/01/2024 | French | |
| Micro model | 30/06/2022 | 30/11/2022 | 19/12/2022 | French | |
| Micro model | 30/06/2021 | 10/12/2021 | 13/12/2021 | French | |
| Micro model | 30/06/2020 | 11/12/2020 | 17/12/2020 | French | |
| Micro model | 30/06/2019 | 17/12/2019 | 17/12/2019 | French | |
| Micro model | 30/06/2018 | 05/12/2018 | 07/12/2018 | French | |
| Micro model | 30/06/2017 | 11/12/2017 | 19/12/2017 | French | |
| Abridged model | 30/06/2016 | 02/12/2016 | 16/12/2016 | French | |
| Abridged model | 30/06/2015 | 01/12/2015 | 15/12/2015 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| DirectorManagerended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Marc LEBLANC | DirectorManager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings11 filings
2014201520162017201820192020202120222023202420252026
DR MARC LEBLANC MALADIE TE CHIRURGIE DES YEUX
Clos Béliau 16, 1421 Ophain-Bois-Seigneur-Isaac
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Clos Béliau 16, 1421 Ophain-Bois-Seigneur-IsaacCurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00579412 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUXCurrent | CBE | |
| DR MARC LEBLANC MALADIE TE CHIRURGIE DES YEUX | accounts 2022 → 2025 | Accounts 2025 · 2025-00579412 |
Events
- 2025Annual accounts 2025132,2 k €↑
- 2024Annual accounts 202498,8 k €↓
- 2023Annual accounts 2023184,3 k €↑
- 2022Annual accounts 2022168,9 k €↑
- 2021Annual accounts 202192,1 k €↑
- 2020Annual accounts 202089,6 k €↓
- 2019Annual accounts 2019142,7 k €↑
- 2018Annual accounts 201890,2 k €↓
- 2017Annual accounts 201796,6 k €↓
- 2016Annual accounts 2016125,8 k €↓
- 2015Annual accounts 2015199,6 k €
- 10/04/2014IncorporationPrivate limited company